Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632264 · ClinicalTrials.gov registry record · NA
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
A NA study of Postpartum Hemorrhage, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT04632264: Completed NA study of Postpartum Hemorrhage, sponsored by Columbia University.
NCT04632264 is a NA study of Postpartum Hemorrhage that has completed, run by Columbia University. The registered enrollment target is 104 participants, below the 775-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04632264, a NA study of Postpartum Hemorrhage, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
Increased blood loss after vaginal or cesarean delivery is one of the top causes of maternal complications. Oxytocin is a common medication given to mothers by IV or an injection to limit the amount of blood loss after delivery. The investigators do not know the best time after delivery that oxytocin should be given. This research is being done to find out if starting the medication oxytocin right after the baby is born or after the placenta comes out decreases the amount of blood lost after birth when we delay cord clamping after birth.
Primary Outcome
Change defined as greater or equal to 1.0 g/dL (≥ 1 standard deviation (SD)) hemoglobin drop between the two arms following a vaginal delivery and greater or equal to 0.9 g/dL (≥ 1SD) following a cesarean delivery.
Conditions Studied
Interventions
- OTHER Saline Placebo
- OTHER Initiation of standard postpartum oxytocin immediately following fetal shoulder delivery
- OTHER Initiation of standard postpartum oxytocin immediately following placenta delivery
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-09-16 |
| Phase | NA |
What the finished NCT04632264 record still lists
NCT04632264 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 775-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 3 interventions - of which Saline Placebo is the first listed.
NCT04632264 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04632264 about?
NCT04632264 is a clinical study titled "Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping". Increased blood loss after vaginal or cesarean delivery is one of the top causes of maternal complications. Oxytocin is a common medication given to mothers by IV or an injection to limit the amount of blood loss after delivery. The investigators do not know the best time after delivery that oxytoci...
What is the current status of trial NCT04632264?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2020-12-10. Estimated completion is 2021-09-16.
What conditions does trial NCT04632264 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT04632264?
The interventions under investigation include: Saline Placebo (OTHER), Initiation of standard postpartum oxytocin immediately following fetal shoulder delivery (OTHER), Initiation of standard postpartum oxytocin immediately following placenta delivery (OTHER).
Who is sponsoring clinical trial NCT04632264?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04632264 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04632264's enrollment target sits among peer trials
104 11th of 19 higher than 9 of 19 other Postpartum Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI